To describe the first clinical experience with the novel purpose-built single-port robotic platform after FDA approval.
Two male patients diagnosed with prostate cancer amenable of radical prostatectomy underwent single-port robot-assisted radical prostatectomy with bilateral pelvic lymph-nodes dissection performed by using the da Vinci SP Surgical System (Intuitive Surgical, Sunnyvale, CA, USA). The surgeries were completed through a 2.5-cm periumbilical incision through which a GelPOINT Mini advanced access platform (Applied Medical, Rancho Santa Margarita, CA, USA) and the dedicated 25-mm multichannel port accommodating a 12 × 10-mm oval articulating robotic camera, three 6-mm double-jointed articulating robotic instruments and a 6-mm accessory laparoscopic instrument were placed. One port for the assistant was placed at the level of the para-rectal line, at the planned final site for the drainage. The primary aim was to report, for the first time in the US after FDA approval of the system, the technical feasibility in the living human. The secondary aim was to report the perioperative outcomes.
The surgeries were successfully completed without conversion. In both cases, the total operative time was 140 minutes. Blood loss were negligible. No complications were recorded. Patients were discharged within 24 hours post-operation.
Herein, we documented the first clinical application of the SP surgical platform for single-port trans-umbilical robot-assisted radical prostatectomy in the USA. This approach will be further investigated regarding the surgical morbidity and the outcomes.
Urology. 2018 Oct 24 [Epub ahead of print]
Jihad Kaouk, Riccardo Bertolo, Mohamed Eltemamy, Juan Garisto
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: ., Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.